Clinical Trial: A Randomized, Double-blind, Placebo-controlled Phase Ia Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of XQ-001 for Inhalation in Healthy Subjects

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918366) titled 'A Randomized, Double-blind, Placebo-controlled Phase Ia Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of XQ-001 for Inhalation in Healthy Subjects' on April 08.

Brief Summary: The primary study objective is to evaluate the safety and tolerability of XQ-001 for inhalation after single and multiple nebulized inhalation administration in healthy Chinese adult subjects.

Study Start Date: Aug. 01, 2024

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Part A - single rising dose 1

Single Dose 1: Inhaled XQ-001

DRUG: Part A - single rising dose 2

Single Dose...